NCT03822052

Brief Summary

Currently, the optimum IV fluid for induction of labor is unknown. The goal of this study is to determine the optimum fluid for induction of labor, D5LR versus LR. The investigators hypothesize that patients assigned to the D5LR group will have a shorter induction of labor when compared to patient's in the LR group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 18, 2019

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 30, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 15, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2019

Completed
Last Updated

December 23, 2019

Status Verified

December 1, 2019

Enrollment Period

8 months

First QC Date

January 18, 2019

Last Update Submit

December 20, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time of induction

    Time from start of labor induction to delivery of infant

    492 min +/- 35 min

Secondary Outcomes (6)

  • Time of Active Labor

    4 hours +/- 3 hours

  • Apgar Scores

    492 min +/- 35 min

  • Mode of Delivery

    492 min +/- 35 min

  • Neonatal ICU admissions

    24 hours after delivery

  • Need for respiratory support

    24 hours after delivery

  • +1 more secondary outcomes

Study Arms (4)

Primiparous Patient, Unfavorable Bishop Score

ACTIVE COMPARATOR

Patient to receive D5LR or LR at 125 cc/hr

Other: Lactated ringersOther: 5% dextrose lactated ringers

Primiparous Patient, Favorable Bishop Score

ACTIVE COMPARATOR

Patient to receive D5LR or LR at 125 cc/hr

Other: Lactated ringersOther: 5% dextrose lactated ringers

Multiparous patient, Unfavorable Bishop Score

ACTIVE COMPARATOR

Patient to receive D5LR or LR at 125 cc/hr

Other: Lactated ringersOther: 5% dextrose lactated ringers

Multiparous patient, Favorable Bishop Score

ACTIVE COMPARATOR

Patient to receive D5LR or LR at 125 cc/hr

Other: Lactated ringersOther: 5% dextrose lactated ringers

Interventions

IV fluid

Multiparous patient, Favorable Bishop ScoreMultiparous patient, Unfavorable Bishop ScorePrimiparous Patient, Favorable Bishop ScorePrimiparous Patient, Unfavorable Bishop Score

IV fluid

Multiparous patient, Favorable Bishop ScoreMultiparous patient, Unfavorable Bishop ScorePrimiparous Patient, Favorable Bishop ScorePrimiparous Patient, Unfavorable Bishop Score

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women, age 18 - 45, that were admitted for induction of labor without any co-morbid conditions and their respective newborns with
  • Induction of labor
  • Singleton pregnancies
  • Vertex presentation
  • Pregnancies at 39 0/7 weeks gestation - 41 6/7 weeks gestation
  • All races/ethnicities

You may not qualify if:

  • Multifetal gestations
  • Noncephalic presentation
  • Preexisting medical conditions:
  • Maternal cardiac disease
  • Lung diseases
  • Chronic hypertension
  • Pregestational or gestational diabetes
  • gHTN or Pre-Eclampsia
  • medical indication for induction of labor (olighydramnios, IUGR)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ascension Genesys Hospital

Grand Blanc, Michigan, 48439, United States

Location

Related Publications (8)

  • Fong A, Serra AE, Caballero D, Garite TJ, Shrivastava VK. A randomized, double-blinded, controlled trial of the effects of fluid rate and/or presence of dextrose in intravenous fluids on the labor course of nulliparas. Am J Obstet Gynecol. 2017 Aug;217(2):208.e1-208.e7. doi: 10.1016/j.ajog.2017.03.010. Epub 2017 Mar 18.

    PMID: 28322776BACKGROUND
  • Sharma C, Kalra J, Bagga R, Kumar P. A randomized controlled trial comparing parenteral normal saline with and without 5% dextrose on the course of labor in nulliparous women. Arch Gynecol Obstet. 2012 Dec;286(6):1425-30. doi: 10.1007/s00404-012-2485-1. Epub 2012 Aug 4.

    PMID: 22865033BACKGROUND
  • ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-397. doi: 10.1097/AOG.0b013e3181b48ef5. No abstract available.

    PMID: 19623003BACKGROUND
  • Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168-e186. doi: 10.1097/AOG.0000000000002351.

    PMID: 28937571BACKGROUND
  • ACOG Committee Opinion No. 761: Cesarean Delivery on Maternal Request. Obstet Gynecol. 2019 Jan;133(1):e73-e77. doi: 10.1097/AOG.0000000000003006.

    PMID: 30575678BACKGROUND
  • ACOG Committee Opinion No. 766: Approaches to Limit Intervention During Labor and Birth. Obstet Gynecol. 2019 Feb;133(2):e164-e173. doi: 10.1097/AOG.0000000000003074.

    PMID: 30575638BACKGROUND
  • Philipson EH, Kalhan SC, Riha MM, Pimentel R. Effects of maternal glucose infusion on fetal acid-base status in human pregnancy. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 1):866-73. doi: 10.1016/s0002-9378(87)80075-3.

    PMID: 3314516BACKGROUND
  • Pare J, Pasquier JC, Lewin A, Fraser W, Bureau YA. Reduction of total labor length through the addition of parenteral dextrose solution in induction of labor in nulliparous: results of DEXTRONS prospective randomized controlled trial. Am J Obstet Gynecol. 2017 May;216(5):508.e1-508.e7. doi: 10.1016/j.ajog.2017.01.010. Epub 2017 Jan 30.

    PMID: 28153654BACKGROUND

MeSH Terms

Interventions

Ringer's Lactate

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DO, Postgraduate Year 3

Study Record Dates

First Submitted

January 18, 2019

First Posted

January 30, 2019

Study Start

March 15, 2019

Primary Completion

November 15, 2019

Study Completion

December 19, 2019

Last Updated

December 23, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations